选择尺寸
关于此项目
Quality Level
agency
BP, ChP, JP, Ph. Eur., USP
product line
EMPROVE® ESSENTIAL
form
fine powder
autoignition temp.
410 °C
quality
E 421
particle size
(see specification)
pH
5-7 (20 °C, 100 g/L in H2O)
bp
290-295 °C/4 hPa
mp
164-169 °C
solubility
213 g/L
application(s)
liquid formulation
pharmaceutical
solid formulation
storage temp.
2-25°C
SMILES string
OC(C(O)C(O)CO)C(O)CO
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2
InChI key
FBPFZTCFMRRESA-UHFFFAOYSA-N
General description
作为Emprove® 计划的一部分,我们的原料随附完备文件,以便助力您制药和生物制药产品合规性、完整供应链透明度以及风险规避。我们的SAFC®产品线经受严格的质控程序检验并遵照适用的cGMP指南生产,提供用于生物药物和药物制剂和生产的优质产品。
Application
Features and Benefits
- 低压片力下具有高压缩性
- 快速崩解和溶出
- 高稀释性
- 无吸湿性,还原糖含量极低
- 保证制剂均匀混合
Legal Information
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
使用 Emprove® 计划保持符合 GMP 要求
使用Emprove® Dossiers可加快资格认证、保持合规性并节省时间。
注意:您将进入 EmproveSuite.com。您的用户名和密码与 SigmaAldrich.com 是分开的,可能不同。
免费注册,几分钟内即可访问 Emprove® Dossiers。 升级您的订阅计划,解锁 Emprove® Suite 中的高级定制内容。
没有找到您要找的内容?访问 Emprove® 计划帮助页面。
商品
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
This article describes the use of excipients to help address API stability issues.
3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.
相关内容
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.